Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |